NK Human Immune System ImmunoGraft® Platform to Evaluate the PD of IO Therapies

Logo
Presented by

Bhavna Verma, PhD, Scientist II, ImmunoOncology Department, Champions Oncology

About this talk

Champions Oncology was excited to participate in the American Association of Cancer Research’s (AACR) Virtual Meeting in June. Due the limited availability of access to these posters, we wanted to give you direct access to our expert researchers and all the details of the newest innovations happening at Champions. Therefore, we have set up Poster Talks with each presenter so that you can register, attend and ask questions live during each session – just like you were at AACR2020 face-to-face. The key poster takeaways you will learn by watching this webinar are: •Learning more about Champions Oncology’s NK ImmunoGraft® platform and it’s applications in vivo using CDX and PDX. •Ex vivo expansion of NK cells and their functionality. •Engraftment using ex vivo expanded and primary NK cells.
Related topics:

More from this channel

Upcoming talks (2)
On-demand talks (55)
Subscribers (3271)
Champions Oncology delivers innovative solutions to oncology drug development, accelerating the journey from the research bench to the clinic – decreasing timelines, lowering costs, and ultimately saving patient lives. Learn more about Champions Oncology's capabilities, our service platforms and educational topics affecting our industry on our Webinar Channel.